Story thread · 2 reports / 2 sources

FDA to hold adcomm for Grail cancer test that failed in large, randomized trial

endpts.com · 4dShare

The FDA will host an advisory committee meeting in September to review Grail's controversial cancer test that failed to meet the primary endpoint of a large, randomized trial in the UK. Grail’s early cancer detection ...

First report: US FDA to Hold Advisory Meeting to Review Grail's Multi-cancer Test — medscape.com, 4d